Sabra Health Care REIT (NASDAQ:SBRA - Get Free Report) issued its quarterly earnings results on Monday. The real estate investment trust reported $0.37 EPS for the quarter, topping analysts' consensus estimates of $0.36 by $0.01, Zacks reports. The business had revenue of $183.54 million during the quarter, compared to the consensus estimate of $180.23 million. Sabra Health Care REIT had a net margin of 18.02% and a return on equity of 4.60%. The company's quarterly revenue was up 10.1% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.35 earnings per share. Sabra Health Care REIT updated its FY 2025 guidance to 1.430-1.460 EPS.
Sabra Health Care REIT Stock Performance
Shares of SBRA traded down $0.09 during mid-day trading on Thursday, reaching $17.98. The company's stock had a trading volume of 946,269 shares, compared to its average volume of 2,153,856. Sabra Health Care REIT has a 1-year low of $13.87 and a 1-year high of $20.03. The business has a 50-day simple moving average of $17.35 and a two-hundred day simple moving average of $17.49. The stock has a market cap of $4.28 billion, a P/E ratio of 33.93, a PEG ratio of 1.97 and a beta of 0.88. The company has a current ratio of 4.32, a quick ratio of 4.16 and a debt-to-equity ratio of 0.88.
Sabra Health Care REIT Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Friday, May 30th. Shareholders of record on Friday, May 16th will be given a dividend of $0.30 per share. The ex-dividend date of this dividend is Friday, May 16th. This represents a $1.20 annualized dividend and a yield of 6.67%. Sabra Health Care REIT's dividend payout ratio (DPR) is presently 203.39%.
Analyst Ratings Changes
Separately, Truist Financial lifted their price objective on shares of Sabra Health Care REIT from $17.00 to $18.00 and gave the company a "hold" rating in a research note on Tuesday, March 18th. Three equities research analysts have rated the stock with a hold rating, three have issued a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, Sabra Health Care REIT presently has a consensus rating of "Moderate Buy" and an average price target of $19.33.
Check Out Our Latest Analysis on Sabra Health Care REIT
About Sabra Health Care REIT
(
Get Free Report)
Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.
Further Reading

Before you consider Sabra Health Care REIT, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sabra Health Care REIT wasn't on the list.
While Sabra Health Care REIT currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.